Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OPHT

IVERIC bio (OPHT) Stock Price, News & Analysis

IVERIC bio logo

About IVERIC bio Stock (NASDAQ:OPHT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.13
$1.39
52-Week Range
N/A
Volume
N/A
Average Volume
159,109 shs
Market Capitalization
$1.65 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OPHT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IVERIC bio and its competitors with MarketBeat's FREE daily newsletter.

OPHT Stock News Headlines

Gossamer Bio Inc GOSS
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Baird Downgrades IVERIC bio (ISEE)
See More Headlines

OPHT Stock Analysis - Frequently Asked Questions

IVERIC bio, Inc. (NASDAQ:OPHT) announced its quarterly earnings results on Wednesday, October, 31st. The biopharmaceutical company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.43) by $0.02.

Based on aggregate information from My MarketBeat watchlists, some other companies that IVERIC bio investors own include iShares Preferred and Income Securities ETF (PFF), Puma Biotechnology (PBYI), Incyte (INCY), Apollo Investment (AINV), BioMarin Pharmaceutical (BMRN), Meta Platforms (META) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
10/31/2018
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OPHT
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$63.09 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$209.98 million
Price / Cash Flow
N/A
Book Value
$3.00 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.65 billion
Optionable
Optionable
Beta
1.49
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:OPHT) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners